Work

Safety of Addition of Inotuzumab Ozogamicin (CMC 544) to Bendamustine, Fludarabine, and Rituximab (BFR) Allogeneic Conditioning for Lymphoid Malignancies

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.3240.3240

Authors: Issa F. Khouri, Alison Gulbis, Denái R. Milton, Martin Körbling, Celina Ledesma, Sairah Ahmed, Amin M. Alousi, Betül Oran, Paolo Anderlini, Stefan O. Ciurea, Roland L. Bassett, Elias Jabbour

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2781992770

FWCI: 0.216

Cites:

Cited by: 1

Related to: 10